Search

Search Constraints

You searched for: Author/Creator Haber, Michelle

Search Results

2. A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children. (30th November 2017)

4. ABCC4/MRP4 contributes to the aggressiveness of Myc‐associated epithelial ovarian cancer. Issue 8 (8th May 2020)

5. Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma. Issue 6 (11th September 2018)

6. Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer. Issue 3 (16th November 2018)

7. DIPG-01. TARGETING THE POLYAMINE PATHWAY AS A NOVEL THERAPEUTIC TREATMENT AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA. Issue 2 (22nd June 2018)

8. DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA. (4th December 2020)

9. DIPG-16. COMBINATION OF ARGININE DEPLETION AND POLYAMINE INHIBITION AS AN ANTICANCER STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). (4th December 2020)

10. DIPG-27. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION. (4th December 2020)